Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
ONB$25.02-0.01(-0.04%)Old National Chairman and CEO Jim Ryan Named Chair-Elect of the American Bankers Association[2:07:00 PM ET]BCRD$5.530.00(0.00%)BlueOne Technologies Announces Enhance Global Remittance Platform[2:04:41 PM ET]CWK$12.13+0.23(+1.93%)Cushman & Wakefield Arranges $130 Million Sale of Seasons of Traverse Mountain in Lehi, Utah[2:01:00 PM ET]CTAS$213.74-12.19(-5.40%)Cintas Corporation Announces Quarterly Cash Dividend[2:00:00 PM ET]QNBC$46.45+0.45(+0.98%)QNB Corp. Reports Third Quarter 2026 Results[1:59:23 PM ET]CNXC$31.36-0.65(-2.03%)Concentrix Breaks the Language Barrier with Live Voice Translation[1:55:00 PM ET]CEG$257.80+5.32(+2.11%)Constellation Secures Conditional DOE Loan Commitment of up to $5 Billion to Expand Nuclear Output[1:35:00 PM ET]TXTM$0.01+0.00(+5.71%)Canouse Announces Unsatisfied Federal Judgment Against Protext Mobility, Inc. (OTC: TXTM)[1:35:00 PM ET]ARAI$0.11-0.00(-1.61%)Arrive AI Installs First Arrive Point(TM) Residential Unit[1:23:00 PM ET]

RVTY · NYSE

Revvity, Inc.

$162.32 +1.88 (+1.17%)

Company overview

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for customers to understand and characterize the health of various aspects, including air, water, and soil.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Market cap
$18.1B
Employees
11,000
Headquarters
Waltham, MA
Website
revvity.com
CEO
Prahlad R. Singh
Listed
July 6, 1965
P/E
77.27
Dividend yield
0.18%

Company financials

Revenue
$2.9B
Gross profit
$1.5B
Operating income
$360M
EBITDA
$774M
Net income
$241M
EPS
$2.10
Total assets
$12B
Total debt
$3.4B
Gross margin
51.44%
Net margin
8.30%
Earnings yield
1.29%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

77.82100.78123.73146.69169.65
RVTY 1D NYSE O159.37H161.67L159.10C160.39+1.62 (+1.02%)Vol1.09M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
RVTYRevvity, Inc. Stock news Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report? Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks Investment Research
RVTYRevvity, Inc. Stock news ELV vs. RVTY: Which Stock Is the Better Value Option? Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity Launches Signals LabGistics to Coordinate Scientific Workflows Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity: A Diagnostics Annuity Is Quietly Funding An AI Data Engine Seeking Alpha
RVTYRevvity, Inc. Stock news Revvity to Present at Upcoming Investor Conferences Business Wire
RVTYRevvity, Inc. Press release Revvity to Host Investor Day Business Wire
RVTYRevvity, Inc. Stock news Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity to Hold Earnings Call on November 3, 2026 Business Wire
RVTYRevvity, Inc. Stock news Revvity (NYSE:RVTY) Hits New 12-Month High – Here’s Why Defense World
RVTYRevvity, Inc. Stock news Here's Why You Should Retain Revvity Stock in Your Portfolio for Now Zacks Investment Research
RVTYRevvity, Inc. Stock news RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes Business Wire
RVTYRevvity, Inc. Stock news Critical Survey: Revvity (NYSE:RVTY) vs. Cytek Biosciences (NASDAQ:CTKB) Defense World
RVTYRevvity, Inc. Stock news Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength? Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript Seeking Alpha
RVTYRevvity, Inc. Stock news Revvity, Inc. (RVTY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Seeking Alpha
RVTYRevvity, Inc. Stock news Revvity to Acquire Human Cell Design to Boost Metabolic Discovery Zacks Investment Research
RVTYRevvity, Inc. Stock news Why Revvity (RVTY) is a Top Momentum Stock for the Long-Term Zacks Investment Research
RVTYRevvity, Inc. Stock news Revvity, Inc. (RVTY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks Transcript Seeking Alpha
See more
FAQ

Questions about Revvity, Inc.

What does Revvity, Inc. do?
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for customers to understand and characterize the health of various aspects, including air, water, and soil.
What is RVTY's market cap?
Revvity, Inc. (RVTY) is a listed stock with a live quote. The latest market cap on this page is $18.1B.
Where is Revvity, Inc. headquartered?
Revvity, Inc. is headquartered in Waltham, MA.
How do I get RVTY news from the API?
Call GET /v1/news?tickers=RVTY. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does RVTY news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for RVTY, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the RVTY price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs